#64 – Putting the Fun in Fungi: A Fun-guide to New Antifungals

1

Introduction

00:00 • 2min

2

The Fun in Antifungals Podcast

02:01 • 2min

3

Invasive Fungal Disease - What Kind of Patient Is It?

04:03 • 5min

4

What Are the Risk Factors of Anti Fungal in Infectious Diseases?

09:23 • 2min

5

Ibrexifunder Is FDA Approved to Treat Volovaginal Candidasis

11:47 • 3min

6

The FDA Approved Antifungal, Otessa Conazole

14:41 • 5min

7

Isavicana Zone a Good Antibiotic?

19:47 • 2min

8

Candidemia

22:14 • 4min

9

MeToo Agent Raise a Function

26:37 • 3min

10

Antifungal Episodes - What's Next?

29:38 • 4min

11

Candida Albacam

33:27 • 2min

12

Opelkonazole

35:04 • 3min

13

Antifungals Sustainability Testing - A Primer for Clinicians

37:54 • 4min

14

The Difference Between Bacterial and Mold Susceptibility Testing

42:18 • 4min

15

How Are Breakpoints Set?

46:22 • 5min

16

What's Your Punchline for Anti-Fungal Susceptibility Testing?

51:41 • 2min

17

Dosing of a Kind of Canons in Critical Illness?

53:53 • 6min

18

I Feel Nerdy - Is That Safe?

59:48 • 2min

19

What's the Coolest Anti-Fungal Moment?

01:01:21 • 5min

20

Do You Expect to Have Openings in Your Lab?

01:06:34 • 2min

21

Is There a Drug That Can Help?

01:08:41 • 3min